Company intelligence / Profile preview

Eticos

Hyderabad, Telangana, India

Ownership: Private
Employees: ~68
Development stage: Other

Overview

Etico Lifesciences specializes in development of generic, specialty, and complex parenteral formulations, including oncological and non-oncological injectables and ophthalmic products. As a CDMO, they do not disclose advanced clinical results for their own pipeline; their development activities primarily focus on product development, technology transfer, and regulatory filings for their clients. Their services cover a range of drug delivery platforms including solutions, emulsions, suspensions, lyophilized injections, liposomes, microspheres, and nanoparticles.

Therapeutic areas: OncologyOphthalmologyOther
Modalities: Small moleculeBiologicMonoclonal antibodyLiposomeMicrosphereNanoparticle
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with leading national and international generic pharmaceutical companies

Beyond the preview

Go deeper on Eticos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eticos.

Explore the full profile